Highlights AstraZeneca Pharma India Limited

Equities

ASTRAZEN

INE203A01020

Delayed Bombay S.E. Other stock markets 12:38:07 2024-07-16 am EDT			5-day change	1st Jan Change
6,720 ^INR	+1.43%		-3.10%	+21.41%

Jul. 03	AstraZeneca Pharma India Limited Receives Order from Deputy Commissioner of Income-Tax, Circle- 1(1)(1), Bangalore	CI
Jul. 03	Astrazeneca Pharma India Limited Appoints Srikanth B.S. as Site Lead, India Operations, Effective August 1, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ex-dividend day for final dividend	Jul. 04	FA
Astrazeneca Pharma India's Net Profit Rises in Fiscal Q4	May. 28	MT
Astrazeneca Pharma India Limited Recommends Dividend for the Financial Year 2023-24	May. 27	CI
AstraZeneca Pharma India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 27	CI
AstraZeneca Pharma India Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 27	CI
Astrazeneca Pharma India Limited Provides Update on Olaparib 100mg and 150 mg Tablets	May. 21	CI
AstraZeneca, Mankind Pharma Tie Up for Exclusive Distribution of Asthma Drug Symbicort in India	Mar. 11	MT
Astrazeneca Pharma India Ltd and Mankind Pharma Partner to Accelerate Access to Asthma Medicine for Patients in India	Mar. 11	CI
AstraZeneca Pharma India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 08	CI
AstraZeneca Gets Indian Drug Regulator's Nod to Import Andexanet Alfa Powder for Solution for Infusion	Jan. 21	MT
Astrazeneca Pharma to Launch Breast Cancer Treatment Drug in India in January 2024	Dec. 21	MT
AstraZeneca Pharma India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09	CI
AstraZeneca Gets Indian Drug Regulator's Nod to Import Pharmaceutical Formulations for Palivizumab	23-10-02	MT
Astrazeneca Pharma India Limited Receives Permission to Import Pharmaceutical Formulations Of New Drug For Sale Or For Distribution In Form CT-20 From Central Drugs Standard Control Organisation For Palivizumab	23-09-30	CI
AstraZeneca Pharma India Limited Approves Dividend for the Financial Year 2022-2023	23-08-17	CI
AstraZeneca Pharma India Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
AstraZeneca Pharma Launches Neurofibromatosis Type 1 Drug in India	23-08-10	MT
AstraZeneca Pharma India Limited Announces Launch of Selumetinib 10 Mg and 25 Mg Capsule	23-08-09	CI
AstraZeneca Pharma India Limited Proposes to Declare Dividend for the Financial Year 2022-23	23-07-22	CI
Ex-dividend day for final dividend	23-07-13	FA

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AstraZeneca Pharma India Limited

Equities

ASTRAZEN

INE203A01020

Highlights

Filters